| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Multiple Sclerosis - Causes, Symptoms and Treatment |
|
E-Articles - Multiple Sclerosis - Causes, Symptoms and Treatment
Multiple Sclerosis(MS)also known as disseminated sclerosis or encephalomyelitis disseminata is a chronic, inflammatory, demyelinating disease that affects the central nervous s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ystem (CNS). Multiple sclerosis affects neurons, the cells of the brain and spinal cord that carry information, create thought and perception, and allow the brain to control th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in body. Surrounding and protecting some of these neurons is a fatty layer known as the myelin sheath, which helps neurons carry electrical signals. MS causes gradual destruction lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of myelin (demyelination) and transection of neuron axons in patches throughout the brain and spinal cord. The name multiple sclerosis refers to the multiple scars (or scleros here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s) on the myelin sheaths. This scarring causes symptoms which vary widely depending upon which signals are interrupted. Multiple sclerosis (MS) usually affects woman more than d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro men. The disorder most commonly begins between ages 20 and 40, but can strike at any age. People with a family history of MS and those who live in a geographical area with a hi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc her incidence rate for MS have a higher risk of the disease. Multiple sclerosis affects an estimated 300,000 people in the United States and probably more than 1 million peopl easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e around the world — including twice as many women as men. Most people experience their first signs or symptoms between ages 20 and 40. MS can cause a variety of symptoms, incl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ding is changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive impairment, problems with balan and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ce, overheating, and pain. Multiple sclerosis may take several different forms, with new symptoms occurring either in discrete attacks or slowly accruing over time. Between att ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cks, symptoms may resolve completely, but permanent neurologic problems often persist, especially as the disease advances. MS will cause impaired mobility and disability in mor ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a severe cases. Causes of Multiple Sclerosis 1.Autoimmune disease. 2.Genetic component. 3.Damage to the Blood-Brain-Barrier. 4.Biochemical events in utero. 5.Allergic reac dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tion 6.Diet and vitamin deficiencies Symptoms of Multiple Sclerosis 1.Double Vision 2.Muscle weakness. 3.Depression. 4.Difficulties with coordination and speech. 5.Overh cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ating. 6.Pain. Treatment of Multiple Sclerosis Several types of therapy have proven to be helpful. Different therapies are used for patients experiencing acute attacks, for tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen patients who have the relapsing-remitting subtype. Interferon medications derived from human cytokines which help regulate the immune system. Physical therapy, speech therapy, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ccupational therapy, and support groups can help improve the person's outlook, reduce depression, maximize function, and improve coping skills. Lioresal (Baclofen), tizanidine ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust (Zanaflex), or a benzodiazepine may be used to reduce muscle spasticity. Steroids are given to decrease the severity of attacks when they occur. These shut the immune system d y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products wn to stop cells from causing inflammation. Mitixantrone medication is effective, but is limited by cardiac toxicity. Interferon beta-1b (Betaseron) and interferon beta-1a (Avo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nex, Rebif) are genetically engineered copies of proteins that occur naturally in your body. They help fight viral infection and regulate your immune system. Glatiramer (Copaxo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e) medication is an alternative to beta interferons if you have relapsing remitting MS. Doctors believe that glatiramer works by blocking your immune system's attack on myelin tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What About A Business To Business Franchise? Ten Tips for Today's Mobile Executive
|